Endo International plc 13D and 13G filings for BIOSPECIFICS TECHNOLOGIES CORP:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-03 8:26 pm Sale |
2020-12-02 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Endo International plc ENDP |
100 100.000% |
-934,973 (-99.99%) |
Filing |
| 2020-10-29 5:24 pm Purchase |
2020-10-19 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Endo International plc ENDP |
935,073 12.700% |
935,073 (New Position) |
Filing |